 | • レポートコード：GIR-105X12953 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、臓器移植用免疫抑制薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。臓器移植用免疫抑制薬の種類別市場規模（抗体、抗増殖剤、カルシニューリン阻害剤、mTOR阻害剤、ステロイド）、用途別市場規模（骨骨髄移植、心臓移植、腎臓移植、肝移植、肺移植）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・臓器移植用免疫抑制薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：F. Hoffmann-La Roche Ltd.、Sanofi、AbbVie, Inc.、Allergan plc.、Astellas Pharma, Inc.、Bristol-Myers Squibb Company、Hoffmann-La Roche Ltd.、GlaxoSmithKline plc、Janssen Pharmaceutical、Novartis AG、Pfizer, Inc.、Veloxis Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：抗体、抗増殖剤、カルシニューリン阻害剤、mTOR阻害剤、ステロイド ・用途別分析2016年-2026年：骨骨髄移植、心臓移植、腎臓移植、肝移植、肺移植 ・臓器移植用免疫抑制薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・臓器移植用免疫抑制薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・臓器移植用免疫抑制薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・臓器移植用免疫抑制薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・臓器移植用免疫抑制薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Organ Transplant Immunosuppressant Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Organ Transplant Immunosuppressant Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Organ Transplant Immunosuppressant Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Organ Transplant Immunosuppressant Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antibodies
Antiproliferative Agents
Calcineurin Inhibitors
mTOR Inhibitors
Steroids
Market segment by Application can be divided into
Bone Marrow Transplant
Heart Transplant
Kidney Transplant
Liver Transplant
Lung Transplant
The key market players for global Organ Transplant Immunosuppressant Drugs market are listed below:
F. Hoffmann-La Roche Ltd.
Sanofi
AbbVie, Inc.
Allergan plc.
Astellas Pharma, Inc.
Bristol-Myers Squibb Company
Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Janssen Pharmaceutical
Novartis AG
Pfizer, Inc.
Veloxis Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Organ Transplant Immunosuppressant Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Organ Transplant Immunosuppressant Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Antibodies
1.2.3 Antiproliferative Agents
1.2.4 Calcineurin Inhibitors
1.2.5 mTOR Inhibitors
1.2.6 Steroids
1.3 Market Analysis by Application
1.3.1 Overview: Global Organ Transplant Immunosuppressant Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Bone Marrow Transplant
1.3.3 Heart Transplant
1.3.4 Kidney Transplant
1.3.5 Liver Transplant
1.3.6 Lung Transplant
1.4 Global Organ Transplant Immunosuppressant Drugs Market Size & Forecast
1.4.1 Global Organ Transplant Immunosuppressant Drugs Sales in Value (2016-2026))
1.4.2 Global Organ Transplant Immunosuppressant Drugs Sales in Volume (2016-2026)
1.4.3 Global Organ Transplant Immunosuppressant Drugs Price by Type (2016-2026) & (USD/ Dose)
1.5 Global Organ Transplant Immunosuppressant Drugs Production Capacity Analysis
1.5.1 Global Organ Transplant Immunosuppressant Drugs Total Production Capacity (2016-2026)
1.5.2 Global Organ Transplant Immunosuppressant Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Organ Transplant Immunosuppressant Drugs Market Drivers
1.6.2 Organ Transplant Immunosuppressant Drugs Market Restraints
1.6.3 Organ Transplant Immunosuppressant Drugs Trends Analysis
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche Ltd.
2.1.1 F. Hoffmann-La Roche Ltd. Details
2.1.2 F. Hoffmann-La Roche Ltd. Major Business
2.1.3 F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Product and Services
2.1.4 F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Organ Transplant Immunosuppressant Drugs Product and Services
2.2.4 Sanofi Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 AbbVie, Inc.
2.3.1 AbbVie, Inc. Details
2.3.2 AbbVie, Inc. Major Business
2.3.3 AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Product and Services
2.3.4 AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Allergan plc.
2.4.1 Allergan plc. Details
2.4.2 Allergan plc. Major Business
2.4.3 Allergan plc. Organ Transplant Immunosuppressant Drugs Product and Services
2.4.4 Allergan plc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Astellas Pharma, Inc.
2.5.1 Astellas Pharma, Inc. Details
2.5.2 Astellas Pharma, Inc. Major Business
2.5.3 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Product and Services
2.5.4 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Bristol-Myers Squibb Company
2.6.1 Bristol-Myers Squibb Company Details
2.6.2 Bristol-Myers Squibb Company Major Business
2.6.3 Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Product and Services
2.6.4 Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Hoffmann-La Roche Ltd.
2.7.1 Hoffmann-La Roche Ltd. Details
2.7.2 Hoffmann-La Roche Ltd. Major Business
2.7.3 Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Product and Services
2.7.4 Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 GlaxoSmithKline plc
2.8.1 GlaxoSmithKline plc Details
2.8.2 GlaxoSmithKline plc Major Business
2.8.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product and Services
2.8.4 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Janssen Pharmaceutical
2.9.1 Janssen Pharmaceutical Details
2.9.2 Janssen Pharmaceutical Major Business
2.9.3 Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Product and Services
2.9.4 Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Novartis AG
2.10.1 Novartis AG Details
2.10.2 Novartis AG Major Business
2.10.3 Novartis AG Organ Transplant Immunosuppressant Drugs Product and Services
2.10.4 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Pfizer, Inc.
2.11.1 Pfizer, Inc. Details
2.11.2 Pfizer, Inc. Major Business
2.11.3 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Product and Services
2.11.4 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Veloxis Pharmaceuticals
2.12.1 Veloxis Pharmaceuticals Details
2.12.2 Veloxis Pharmaceuticals Major Business
2.12.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product and Services
2.12.4 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Organ Transplant Immunosuppressant Drugs Sales by Manufacturer
3.1 Global Organ Transplant Immunosuppressant Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Organ Transplant Immunosuppressant Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Organ Transplant Immunosuppressant Drugs Manufacturer Market Share
3.4.2 Top 6 Organ Transplant Immunosuppressant Drugs Manufacturer Market Share
3.5 Global Organ Transplant Immunosuppressant Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Organ Transplant Immunosuppressant Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Organ Transplant Immunosuppressant Drugs Market Size by Region
4.1.1 Global Organ Transplant Immunosuppressant Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Region (2016-2026)
4.2 North America Organ Transplant Immunosuppressant Drugs Revenue (2016-2026)
4.3 Europe Organ Transplant Immunosuppressant Drugs Revenue (2016-2026)
4.4 Asia-Pacific Organ Transplant Immunosuppressant Drugs Revenue (2016-2026)
4.5 South America Organ Transplant Immunosuppressant Drugs Revenue (2016-2026)
4.6 Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Organ Transplant Immunosuppressant Drugs Sales in Volume by Type (2016-2026)
5.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2016-2026)
5.3 Global Organ Transplant Immunosuppressant Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Organ Transplant Immunosuppressant Drugs Sales in Volume by Application (2016-2026)
6.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2016-2026)
6.3 Global Organ Transplant Immunosuppressant Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2026)
7.2 North America Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2026)
7.3 North America Organ Transplant Immunosuppressant Drugs Market Size by Country
7.3.1 North America Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2026)
8.2 Europe Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2026)
8.3 Europe Organ Transplant Immunosuppressant Drugs Market Size by Country
8.3.1 Europe Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Organ Transplant Immunosuppressant Drugs Market Size by Region
9.3.1 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2026)
10.2 South America Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2026)
10.3 South America Organ Transplant Immunosuppressant Drugs Market Size by Country
10.3.1 South America Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Organ Transplant Immunosuppressant Drugs Market Size by Country
11.3.1 Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Organ Transplant Immunosuppressant Drugs Typical Distributors
12.3 Organ Transplant Immunosuppressant Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Organ Transplant Immunosuppressant Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Organ Transplant Immunosuppressant Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. F. Hoffmann-La Roche Ltd. Major Business
Table 5. F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Product and Services
Table 6. F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Organ Transplant Immunosuppressant Drugs Product and Services
Table 10. Sanofi Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. AbbVie, Inc. Major Business
Table 13. AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Product and Services
Table 14. AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Allergan plc. Basic Information, Manufacturing Base and Competitors
Table 16. Allergan plc. Major Business
Table 17. Allergan plc. Organ Transplant Immunosuppressant Drugs Product and Services
Table 18. Allergan plc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Astellas Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Astellas Pharma, Inc. Major Business
Table 21. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Product and Services
Table 22. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Company Major Business
Table 25. Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Product and Services
Table 26. Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Hoffmann-La Roche Ltd. Major Business
Table 29. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Product and Services
Table 30. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline plc Major Business
Table 33. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product and Services
Table 34. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Janssen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Janssen Pharmaceutical Major Business
Table 37. Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Product and Services
Table 38. Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 40. Novartis AG Major Business
Table 41. Novartis AG Organ Transplant Immunosuppressant Drugs Product and Services
Table 42. Novartis AG Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer, Inc. Major Business
Table 45. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Product and Services
Table 46. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Veloxis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Veloxis Pharmaceuticals Major Business
Table 49. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product and Services
Table 50. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales (K Doses), Price (USD/ Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Organ Transplant Immunosuppressant Drugs Sales by Manufacturer (2019-2021e) & (K Doses)
Table 52. Global Organ Transplant Immunosuppressant Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Organ Transplant Immunosuppressant Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Organ Transplant Immunosuppressant Drugs Production Capacity by Company, (K Doses): 2020 VS 2021
Table 55. Head Office and Organ Transplant Immunosuppressant Drugs Production Site of Key Manufacturer
Table 56. Global Organ Transplant Immunosuppressant Drugs Sales by Region (2016-2021e) & (K Doses)
Table 57. Global Organ Transplant Immunosuppressant Drugs Sales by Region (2021-2026) & (K Doses)
Table 58. Global Organ Transplant Immunosuppressant Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Organ Transplant Immunosuppressant Drugs Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2021e) & (K Doses)
Table 61. Global Organ Transplant Immunosuppressant Drugs Sales by Type (2021-2026) & (K Doses)
Table 62. Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Organ Transplant Immunosuppressant Drugs Price by Type (2016-2021e) & (USD/ Dose)
Table 65. Global Organ Transplant Immunosuppressant Drugs Price by Type (2021-2026) & (USD/ Dose)
Table 66. Global Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2021e) & (K Doses)
Table 67. Global Organ Transplant Immunosuppressant Drugs Sales by Application (2021-2026) & (K Doses)
Table 68. Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Organ Transplant Immunosuppressant Drugs Price by Application (2016-2021e) & (USD/ Dose)
Table 71. Global Organ Transplant Immunosuppressant Drugs Price by Application (2021-2026) & (USD/ Dose)
Table 72. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021e) & (K Doses)
Table 73. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2021-2026) & (K Doses)
Table 74. North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2021e) & (K Doses)
Table 77. North America Organ Transplant Immunosuppressant Drugs Sales by Type (2021-2026) & (K Doses)
Table 78. North America Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2021e) & (K Doses)
Table 79. North America Organ Transplant Immunosuppressant Drugs Sales by Application (2021-2026) & (K Doses)
Table 80. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021e) & (K Doses)
Table 81. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2021-2026) & (K Doses)
Table 82. Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2021e) & (K Doses)
Table 85. Europe Organ Transplant Immunosuppressant Drugs Sales by Type (2021-2026) & (K Doses)
Table 86. Europe Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2021e) & (K Doses)
Table 87. Europe Organ Transplant Immunosuppressant Drugs Sales by Application (2021-2026) & (K Doses)
Table 88. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2016-2021e) & (K Doses)
Table 89. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2021-2026) & (K Doses)
Table 90. Asia-Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2021e) & (K Doses)
Table 93. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Type (2021-2026) & (K Doses)
Table 94. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2021e) & (K Doses)
Table 95. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Application (2021-2026) & (K Doses)
Table 96. South America Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021e) & (K Doses)
Table 97. South America Organ Transplant Immunosuppressant Drugs Sales by Country (2021-2026) & (K Doses)
Table 98. South America Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Organ Transplant Immunosuppressant Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2021e) & (K Doses)
Table 101. South America Organ Transplant Immunosuppressant Drugs Sales by Type (2021-2026) & (K Doses)
Table 102. South America Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2021e) & (K Doses)
Table 103. South America Organ Transplant Immunosuppressant Drugs Sales by Application (2021-2026) & (K Doses)
Table 104. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021e) & (K Doses)
Table 105. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2021-2026) & (K Doses)
Table 106. Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2021e) & (K Doses)
Table 109. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales by Type (2021-2026) & (K Doses)
Table 110. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2021e) & (K Doses)
Table 111. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales by Application (2021-2026) & (K Doses)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Organ Transplant Immunosuppressant Drugs Typical Distributors
Table 115. Organ Transplant Immunosuppressant Drugs Typical Customers
List of Figures
Figure 1. Organ Transplant Immunosuppressant Drugs Picture
Figure 2. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2020
Figure 3. Antibodies
Figure 4. Antiproliferative Agents
Figure 5. Calcineurin Inhibitors
Figure 6. mTOR Inhibitors
Figure 7. Steroids
Figure 8. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2020
Figure 9. Bone Marrow Transplant
Figure 10. Heart Transplant
Figure 11. Kidney Transplant
Figure 12. Liver Transplant
Figure 13. Lung Transplant
Figure 14. Global Organ Transplant Immunosuppressant Drugs Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 15. Global Organ Transplant Immunosuppressant Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Organ Transplant Immunosuppressant Drugs Sales (2016-2026) & (K Doses)
Figure 36. Global Organ Transplant Immunosuppressant Drugs Production Capacity (2016-2026) & (K Doses)
Figure 37. Global Organ Transplant Immunosuppressant Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Organ Transplant Immunosuppressant Drugs Market Drivers
Figure 39. Organ Transplant Immunosuppressant Drugs Market Restraints
Figure 40. Organ Transplant Immunosuppressant Drugs Market Trends
Figure 41. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Manufacturer in 2020
Figure 42. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Manufacturer in 2020
Figure 43. Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Organ Transplant Immunosuppressant Drugs Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Organ Transplant Immunosuppressant Drugs Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2016-2026)
Figure 47. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2016-2026)
Figure 48. North America Organ Transplant Immunosuppressant Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Europe Organ Transplant Immunosuppressant Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Organ Transplant Immunosuppressant Drugs Revenue (2016-2026) & (USD Million)
Figure 51. South America Organ Transplant Immunosuppressant Drugs Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue (2016-2026) & (USD Million)
Figure 53. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2016-2026)
Figure 54. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2016-2026)
Figure 55. Global Organ Transplant Immunosuppressant Drugs Price by Type (2016-2026) & (USD/ Dose)
Figure 56. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2016-2026)
Figure 57. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2016-2026)
Figure 58. Global Organ Transplant Immunosuppressant Drugs Price by Application (2016-2026) & (USD/ Dose)
Figure 59. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2026)
Figure 60. North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2026)
Figure 61. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2016-2026)
Figure 62. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2016-2026)
Figure 63. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2026)
Figure 64. Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2026)
Figure 65. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2016-2026)
Figure 66. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2016-2026)
Figure 71. South America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2026)
Figure 72. South America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2026)
Figure 73. South America Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2016-2026)
Figure 74. South America Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
臓器移植免疫抑制薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation. Scope of the Report: This repor…- 移植診断の世界市場2018-2025 The demand of transplant diagnostics is increasing repuily.The Transplant Diagnostics market was valued at xx Million US$ in 2017 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 a…
- 臓器保存の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Organ preservation is the supply line for organ transplantation. Currently, the liver, pancreas, and kidney can be successfully preserved for up to two days by flushing the organs with the University of Wisconsin (UW) organ preservation solution and storing them at hypothermia (0-5 degree C). Scope …
- 腎臓がんの薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) of the renal pelvis. These names reflect the type of cell from which the cancer devel…
- HLAタイピング移植の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Human leukocyte antigen (HLA) typing is used to match patients and donors for bone marrow or cord blood transplants. HLA are proteins -- or markers -- found on most cells in your body. Your immune system uses these markers to recognize which cells belong in your body and which do not. Scope of the R…